River Investment Partners, a US-based investment company, has acquired a non-controlling interest in NYSE-listed Life Sciences Research and Cambridgeshire-based Huntingdon Life Science. The interest consists of a loan and commitment to financing and was acquired from Anchor Sub Funding
Related Stories
Related Topics
Early Stage Funding